The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- New Jersey Train Length, Crew Size Law Awaits Governor’s Signature
- CSX Conductor, Single Mother Devastated in Head-on Collision
- SOFA Safety Alert
- AJFL Scholarship Application Opens Soon
- SMART-TD Applauds FRA and DOT for Strengthening Cross-Border Rail Safety Protections
- Regional Training Seminars coming to St. Paul, Baltimore in 2026
- Transit Funding Boost Proposed by SMART-TD Backed Bill
- California SMART-TD Brother Killed on the Job
- Union Mourns the Loss of Brother Charles Harrison
- FRA Issues Grade-Crossing Safety Advisory